Eps Summary of Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals Inc.'s latest annual eps in 2023 was -0.45 CAD , up 38.36% from previous year.
Algernon Pharmaceuticals Inc.'s latest quarterly eps in 2024 Q3 was 0.07 CAD , up 214.94% from previous quarter.
Algernon Pharmaceuticals Inc. reported an annual eps of -0.73 CAD in 2022, up 29.81% from previous year.
Algernon Pharmaceuticals Inc. reported an annual eps of -1.04 CAD in 2021, up 48.77% from previous year.
Algernon Pharmaceuticals Inc. reported a quarterly eps of 0.07 CAD for 2024 Q3, up 214.94% from previous quarter.
Algernon Pharmaceuticals Inc. reported a quarterly eps of -0.03 CAD for 2024 Q1, up 79.31% from previous quarter.

Annual Eps Chart of Algernon Pharmaceuticals Inc. (2023 - 2015)

Historical Annual Eps of Algernon Pharmaceuticals Inc. (2023 - 2015)

Year	Eps	Eps Growth
2023	-0.45 CAD	38.36%
2022	-0.73 CAD	29.81%
2021	-1.04 CAD	48.77%
2020	-2.03 CAD	-128.09%
2019	-0.89 CAD	-27.14%
2018	-0.70 CAD	54.55%
2017	-1.54 CAD	81.15%
2016	-8.17 CAD	-134.1%
2015	-3.49 CAD	0.0%

Year	Eps	Eps Growth
2024 Q2	-0.05 CAD	-57.7%
2024 Q3	0.07 CAD	214.94%
2024 Q1	-0.03 CAD	79.31%
2023 Q1	-0.17 CAD	37.04%
2023 Q4	-0.16 CAD	-60.0%
2023 FY	- CAD	38.36%
2023 Q3	-0.10 CAD	-208.64%
2023 Q2	-0.03 CAD	80.94%
2022 Q1	-0.15 CAD	-400.0%
2022 Q4	-0.27 CAD	-125.0%
2022 Q3	-0.12 CAD	55.56%
2022 Q2	-0.27 CAD	-80.0%
2022 FY	- CAD	29.81%
2021 Q4	-0.03 CAD	85.71%
2021 Q3	-0.21 CAD	40.0%
2021 FY	- CAD	48.77%
2021 Q2	-0.35 CAD	32.69%
2021 Q1	-0.52 CAD	99.92%
2020 Q2	-0.22 CAD	-248.1%
2020 FY	- CAD	-128.09%
2020 Q3	-0.93 CAD	-322.73%
2020 Q4	-625.17 CAD	-67122.58%
2020 Q1	-0.06 CAD	99.97%
2019 Q4	-224.43 CAD	-93412.5%
2019 Q2	-0.20 CAD	28.57%
2019 Q1	-0.28 CAD	99.83%
2019 FY	- CAD	-27.14%
2019 Q3	-0.24 CAD	-20.0%
2018 Q1	-0.14 CAD	99.95%
2018 FY	- CAD	54.55%
2018 Q4	-166.32 CAD	-57251.72%
2018 Q3	-0.29 CAD	-141.67%
2018 Q2	-0.12 CAD	14.29%
2017 Q3	-0.59 CAD	-126.92%
2017 FY	- CAD	81.15%
2017 Q4	-266.56 CAD	-45079.66%
2017 Q1	-0.58 CAD	99.83%
2017 Q2	-0.26 CAD	55.17%
2016 Q1	-10.82 CAD	-641.1%
2016 Q4	-333.66 CAD	-65323.53%
2016 Q3	-0.51 CAD	72.73%
2016 Q2	-1.87 CAD	82.72%
2016 FY	- CAD	-134.1%
2015 Q3	-1.07 CAD	0.0%
2015 Q4	-1.46 CAD	-36.45%
2015 FY	- CAD	0.0%

Peer Eps Comparison of Algernon Pharmaceuticals Inc.

Name	Eps	Eps Difference
Nuo Therapeutics, Inc.	-0.08 USD	-496.817%
CNBX Pharmaceuticals Inc.	-0.42 USD	-7.143%
Mosaic ImmunoEngineering Inc.	-0.33 USD	-36.364%
Evofem Biosciences, Inc.	10.35 USD	104.348%
GB Sciences, Inc.	-0.00 USD	-10875.61%
Inhibitor Therapeutics, Inc.	-0.02 USD	-2150.0%
NanoSphere Health Sciences Inc.	-0.02 USD	-1927.027%
Skye Bioscience, Inc.	-5.37 USD	91.62%
Zenith Capital Corp.	-0.07 USD	-543.777%
Agentix Corp.	-0.04 USD	-1185.714%
Arch Therapeutics, Inc.	-2.27 USD	80.176%
Biomind Labs Inc.	-0.02 USD	-2677.778%
ContraFect Corporation	-124.97 USD	99.64%
CSL Limited	2.73 USD	116.484%
CytoDyn Inc.	-0.05 USD	-750.662%
GlobeStar Therapeutics Corporation	-0.00 USD	-18650.0%
Neon Bloom, Inc.	-0.00 USD	-29900.0%
Northwest Biotherapeutics, Inc.	-0.06 USD	-682.609%
ProtoKinetix, Incorporated	-0.01 USD	-4400.0%
Propanc Biopharma, Inc.	-0.02 USD	-1798.734%
Regen BioPharma, Inc.	0.26 USD	273.077%
Santhera Pharmaceuticals Holding AG	5.95 USD	107.563%
SQZ Biotechnologies Company	-2.76 USD	83.696%
Therapeutic Solutions International, Inc.	-0.00 USD	-64185.714%
Eiger BioPharmaceuticals, Inc.	-50.78 USD	99.114%
Intellipharmaceutics International Inc.	-0.09 USD	-414.874%
Mesoblast Limited	-0.09 USD	-405.051%
Marizyme, Inc.	-1.44 USD	68.75%
Genus plc	0.12 USD	475.0%
Pharming Group N.V.	-0.02 USD	-2695.031%
Nymox Pharmaceutical Corporation	-0.10 USD	-366.321%
RegeneRx Biopharmaceuticals, Inc.	-0.01 USD	-3650.0%
IMV Inc.	-4.37 USD	89.703%
AXIM Biotechnologies, Inc.	-0.04 USD	-1171.186%
MultiCell Technologies, Inc.	-0.00 USD	-449900.0%
ONE Bio Corp.	1.43 USD	131.469%
RVL Pharmaceuticals plc	-0.58 USD	22.414%
Arno Therapeutics, Inc.	- USD	Infinity%
Emmaus Life Sciences, Inc.	-0.07 USD	-540.114%
Provectus Biopharmaceuticals, Inc.	-0.01 USD	-5981.081%
Oncotelic Therapeutics, Inc.	-0.02 USD	-2161.307%
THC Farmaceuticals, Inc.	-0.00 USD	-56150.0%
Acro Biomedical Co., Ltd.	-0.26 USD	-73.077%
Alpha Cognition Inc.	-0.15 USD	-200.0%
Enzolytics Inc.	-0.00 USD	-64185.714%
MetaStat, Inc.	- USD	Infinity%
argenx SE	-5.16 USD	91.279%
Enzon Pharmaceuticals, Inc.	0.00 USD	34715.385%
Endonovo Therapeutics, Inc.	0.03 USD	1892.829%
Genscript Biotech Corporation	-0.05 USD	-891.189%
Nanobac Pharmaceuticals, Incorporated	- USD	Infinity%
Institute of Biomedical Research Corp.	-0.05 USD	-773.786%
Sigyn Therapeutics, Inc.	-3.77 USD	88.064%
WPD Pharmaceuticals Inc.	-0.00 USD	-89900.0%
Cotinga Pharmaceuticals Inc.	-0.09 USD	-392.881%
VioQuest Pharmaceuticals, Inc.	-2.33 USD	80.687%
PsyBio Therapeutics Corp.	-0.04 USD	-971.429%
Adynxx, Inc.	- USD	Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	Infinity%
Accustem Sciences Inc.	-0.34 USD	-32.353%
Helix BioMedix, Inc.	-4.70 USD	90.426%
EV Biologics, Inc.	-0.12 USD	-275.0%
Q BioMed Inc.	-0.08 USD	-476.184%
Capstone Therapeutics Corp.	-36.39 USD	98.763%
American Oriental Bioengineering, Inc.	-781.24 USD	99.942%
TetraLogic Pharmaceuticals Corporation	- USD	Infinity%
BioStem Technologies, Inc.	-0.62 USD	27.419%
Curative Biotechnology, Inc.	-0.01 USD	-5013.636%
HST Global, Inc.	-0.03 USD	-1512.903%
Burzynski Research Institute, Inc.	-0.01 USD	-4311.765%
Wesana Health Holdings Inc.	-0.05 USD	-798.204%
Halberd Corporation	-0.00 USD	-449900.0%
Resverlogix Corp.	-0.01 USD	-3069.014%
Cell Source, Inc.	-0.17 USD	-164.706%
RespireRx Pharmaceuticals Inc.	-0.04 USD	-1160.504%
GeneThera, Inc.	- USD	Infinity%
AVAX Technologies, Inc.	-0.05 USD	-734.879%
Ember Therapeutics, Inc.	-0.01 USD	-7042.857%
Anthera Pharmaceuticals, Inc.	- USD	Infinity%
NovAccess Global Inc.	-0.23 USD	-95.652%
Kadimastem Ltd	-0.78 USD	42.308%
VitaSpring Biomedical Co. Ltd.	- USD	Infinity%
Rasna Therapeutics, Inc.	-0.01 USD	-4400.0%
Oncology Pharma Inc.	- USD	Infinity%
Reve Technologies, Inc.	-0.01 USD	-3681.513%
LadRx Corporation	0.68 USD	166.176%
Regen BioPharma, Inc.	0.29 USD	255.172%
Affymax, Inc.	-0.39 USD	-15.385%
Itoco Inc.	-0.01 USD	-5821.053%
Pathfinder Cell Therapy, Inc.	-0.00 USD	-17900.0%
Mobile Lads Corp.	-0.01 USD	-7935.714%
International Stem Cell Corporation	-0.02 USD	-2643.902%
Claritas Pharmaceuticals, Inc.	- USD	Infinity%
Bioxytran, Inc.	-0.03 USD	-1310.658%
NDT Pharmaceuticals Inc.	-0.00 USD	-89900.0%
Qrons Inc.	-0.06 USD	-671.87%
Alseres Pharmaceuticals, Inc.	-153.67 USD	99.707%
SYBLEU INC	-0.02 USD	-2471.429%
Advanced Proteome Therapeutics Corporation	- USD	Infinity%
Nascent Biotech, Inc.	-0.01 USD	-3258.209%
Rebus Holdings, Inc.	-0.03 USD	-1301.869%
ImmunoCellular Therapeutics, Ltd.	-0.01 USD	-3069.014%
GlobeImmune, Inc.	- USD	Infinity%
Predictive Technology Group, Inc.	- USD	Infinity%
ProText Mobility, Inc.	- USD	Infinity%
Cardax, Inc.	- USD	Infinity%
VG Life Sciences Inc.	-0.00 USD	-449900.0%
Kaleido Biosciences, Inc.	- USD	Infinity%
Advaxis, Inc.	-7.99 USD	94.368%
Adhera Therapeutics, Inc.	-1.18 USD	61.864%
RenovaCare, Inc.	- USD	Infinity%
Regnum Corp.	-0.03 USD	-1223.529%
Innovation Pharmaceuticals Inc.	-0.01 USD	-7042.857%
Neutra Corp.	-0.00 USD	-449900.0%
Windtree Therapeutics, Inc.	-94.23 USD	99.522%
PureTech Health plc	-2.38 USD	81.092%
Coeptis Therapeutics, Inc.	-0.83 USD	45.783%
IXICO plc	-0.02 USD	-1744.262%
IntelGenx Technologies Corp.	-0.06 USD	-692.254%
Gelesis Holdings, Inc.	-1.35 USD	66.667%
CSL Limited	5.47 USD	108.227%
Cellectis S.A.	-1.77 USD	74.576%

Global Stocks Search

Algernon Pharmaceuticals Inc. (AGNPF)

Eps Summary of Algernon Pharmaceuticals Inc.

Annual Eps Chart of Algernon Pharmaceuticals Inc. (2023 - 2015)

Historical Annual Eps of Algernon Pharmaceuticals Inc. (2023 - 2015)

Peer Eps Comparison of Algernon Pharmaceuticals Inc.